Co-Founders

Dr. David Margulies

Health and Technology Entrepreneur

Professional Bio

As a physician executive and entrepreneur with interests in computational biology, genetics, and neuroscience, David has founded and led multiple technology-based health services companies. In the 1980s, he created the first clinical computing programs at both Columbia Presbyterian Medical Center and Boston Children’s Hospital, serving as Boston Children’s Hospital’s first Chief Information Officer. He then served as Executive Vice President, Chief Scientist, and Director of Cerner Corporation. David also co-founded and served in leadership roles at CareInsite (now WebMD), Correlagen Diagnostics (acquired by LabCorp), Generation Health (acquired by CVS/Caremark), and Claritas Genomics (now QnA Diagnostics). More recently, David returned to Boston Children’s Hospital as Vice President of Strategy and co-founded and served as Chief Executive Officer and Chairman of the Board at Q-State Biosciences.  David is a graduate of Amherst College and Harvard Medical School, and board certified in Internal Medicine. He holds an appointment as Assistant Professor at Harvard Medical School in the Department of Bioinformatics and at Boston Children’s Hospital in the Division of Genetics.

Close Bio

Dr. Adam Cohen

Professor, Harvard University

Professional Bio

Adam E. Cohen is a professor in the departments of Chemistry and Chemical Biology and Physics at Harvard, with secondary appointments in the Center for Brain Science and the Harvard Stem Cell Institute. He is also an investigator with the Howard Hughes Medical Institute. At Harvard, Adam and his lab have developed numerous tools to study biological molecules and cells, most notably Optopatch technology. This first-of-its-kind technology uses genetically encoded fluorescent reporters to examine electrical activity in neurons.  The Optopatch technology is commercially licensed exclusively to Q-State, where it is used to characterize cellular models of nervous system disorders.  Adam has received Young Investigator Awards from the Office of Naval Research, the Dreyfus Foundation, the Sloan Foundation, and many other organizations. Technology Review Magazine named Adam one of the top 35 US technological innovators under the age of 35, Popular Science named him one of their “Brilliant Ten” top young scientists, and President Obama awarded him a Presidential Early Career Award for Scientists and Engineers.  Adam holds an A.B. in chemistry and physics from Harvard, a Ph.D. in experimental biophysics from Stanford, and a Ph.D. in theoretical physics from the University of Cambridge.

Close Bio

Dr. Kevin Eggan

Professor, Harvard University

Professional Bio

Kevin Eggan is a professor in the department of Stem Cell and Regenerative Biology at Harvard and Director of the Stem Cell program at the Broad Institute’s Stanley Center. He garnered international recognition for his seminal work in stem cell biology, receiving the MacArthur Foundation “Genius Grant” in 2006 and being selected as a Howard Hughes Medical Institute Early Career Scientist. His current research focuses on using stem cell technologies to better understand nervous system disorders such as amyotrophic lateral sclerosis (ALS) and schizophrenia, with the aim of developing new therapeutics. Kevin received a B.S. from the University of Illinois and a Ph.D. from the Massachusetts Institute of Technology.

Close Bio